Market Analysis — BACHARACH INSTITUTE FOR REHABILITATI
NJ market | 4 hospitals | HHI: 5,827 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
4
Hospitals in Market
841
Total Beds
$1.1B
Market Revenue
Concentrated
HHI: 5,827
None
Moat Rating (0/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share2.4%
Top 3 Concentration98.1%
Network Density0.48
Margin vs Market-11.8%
Bed Util vs Market-26.8%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NJ market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 5,827).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NJ market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| ATLANTICARE REGIONAL MEDICAL CENTER | 532 | $791M | 72.7% | 63.3% |
| SHORE MEMORIAL HOSPITAL | 199 | $250M | 23.0% | 23.7% |
| SSH - ATLANTIC CITY | 30 | $21M | 1.9% | 3.6% |
Regional Payer Mix
■ Medicare 53%■ Medicaid 4%■ Commercial 44%